A Phase II Trial of Carboplatin Plus Cetuximab for the Treatment of Stage IIIb/IV Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2010
At a glance
- Drugs Carboplatin; Cetuximab
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors ImClone Systems
- 18 Nov 2008 Checked against ClinicalTrials.gov record.
- 01 Oct 2008 Actual number of patients enrolled was 50 according to ClinicalTrials.gov record.
- 16 Aug 2005 New trial record.